Print Create a hardcopy of this page Font Size: Default font size Larger font size National Public Health Week now under way Observation recognizes strides made, changes needed in US health system Posted: Monday, April 7, 2014 11:07 am Ertel Medicine now offering genetic testing Ertel Medicine and Pediatrics is now offering special genetic testing called pharmocogenetic testing. The test helps the medical provideradminister the most accurate treatment based on each patients unique science. Since everyone processes medications differently, this may be the key to help my patientsget to the sweet spot sooner, Dr. Larry Ertel said in a news release. Whether it is Plavix (a heart medicine) which is known to havesevere adverse reactions if the dose is too high or just a common reflux medicine or even anti-depressants I will be able to see how a patient metabolizes medicine and adjust accordingly. An online service is needed to view this article in its entirety. You need an online service to view this article in its entirety. With this digital membership, you not only get unlimited access to The Winchester Sun website but to the e-edition as well. With this digital membership, you get unlimited access to websites of … Continue reading →

Irvine, CA (PRWEB) April 07, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented research from three studies at the American Society of Interventional Pain Physicians' (ASIPP) 16th annual meeting in New Orleans. The event took place at the Hilton New Orleans Riverside hotel, this weekend, April 4-6. Proove submitted abstracts on three IRB-approved clinical studies to ASIPP for presentation at the annual meeting. Out of many abstracts submitted by various researchers, ASIPP only accepted 20 studies for presentation and publication. All three Proove study abstracts were accepted for poster presentation, and one of Proove's study abstracts was selected in the "Top 5 Posters" presented before the general session on Saturday afternoon. Specifically, the company plans to present: Predictive Risk of Injury Complications Enduring Over one Year Using Genetic Predisposition (P.R.I.C.E.) Study, MED Scale to Predict Hydrocodone Efficacy versus the Pain VAS Score Study, and Perception of Analgesia in Narcotic Users with Chronic Pain: A Multi-Center Cross-Sectional Study Comparing Genotype to Pain VAS (P.A.I.N.) Study. On Saturday afternoon, Proove's Medical Director for Pain and Addiction, Daniel Schwarz, MD, MROC presented information on Prooves P.R.I.C.E. study during the "Top 5 Posters" session. The PRICE Study demonstrates … Continue reading →

UC Davis School of Veterinary Medicine researchers have identified the genetic mutation responsible for a form of cleft palate in the dog breed Nova Scotia Duck Tolling Retrievers. They hope that the discovery, which provides the first dog model for the craniofacial defect, will lead to a better understanding of cleft palate in humans. Although cleft palate is one of the most common birth defects in children, affecting approximately one in 1,500 live human births in the United States, it is not completely understood. The findings appear this week online in the journal PLOS Genetics and are available at https://tinyurl.com/knr8wb3. "This discovery provides novel insight into the genetic cause of a form of cleft palate through the use of a less conventional animal model," said Professor Danika Bannasch, a veterinary geneticist who led the study. "It also demonstrates that dogs have multiple genetic causes of cleft palate that we anticipate will aid in the identification of additional candidate genes relevant to human cleft palate." Bannasch, who holds the Maxine Adler endowed chair in genetics, explains that common breeding practices have made the dog a unique animal model to help understand the genetic basis of naturally occurring birth defects. By conducting … Continue reading →

By: Ina Zara, News5 April 7, 2014 9:05 PM Contributed file photo of Katherine Grace Tan. InterAksyon.com The online news portal of TV5 MANILA, Philippines A cum laude graduate from the Ateneo de Manila University, who was suffering from Hodgkin's lymphoma, died last year after undergoing embryonic stem cell therapy that was allegedly administered by Antonia Park, the alternative medicine doctor of former President Gloria Macapagal-Arroyo. Bernard Tan claimed that Park had promised that within three months, his 23-year-old daughter, Katherine Grace Tan, would be cured of her disease, which according to the doctor was not cancer but just hormonal imbalance. But after undergoing treatment and strictly following a juice diet, Katherine got weaker and died. Earlier this month, it was reported that Park, of the Green & Young Health & Wellness Center,admitted that she wasnt licensed to practice in the Philippines. Records from the theProfessional Regulatory Commission as of August 2013 showed that Park was not on the list of physicians authorized to practice medicine in the country. Link: VIDEO | Ateneo graduate dies after undergoing stem cell therapy … Continue reading →

Contact Information Available for logged-in reporters only Newswise SAN FRANCISCO (April 7, 2014) The devastating effects of stroke have long led physicians to conclude that lost brain function is irreversible. Today during the 82nd Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS), researchers presented the results of a groundbreaking study that offers new hope to stroke patients. In the first North American trial of its kind, researchers conducted intraparenchymal transplantation of bone marrow-derived cell therapy in chronic stroke patients. Titled A Novel Phase 1/2A Study of Intraparenchymal Transplantation of Human Modified Bone Marrow Derived Cells in Patients with Stable Ischemic Stroke, the study tested the feasibility of administering escalated doses of stromal cells. Numerous preclinical animal stroke studies showing the benefit of stem cell transplantation led to the initiation of this clinical trial. The study was led by Gary K. Steinberg, MD, PhD, FAANS: Although this was primarily a safety study, we found a significant recovery of neurologic function in patients overall at six months that is sustained at one year. Two of the 18 transplanted patients showed remarkable improvement. Transplanted patients continued to recover substantial neurologic function two years or more following their stroke, said Dr. … Continue reading →